Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octafibrin versus cryoprecipitate in cytoreductive surgery for pseudomyxoma peritonei
2016-003749-27Phase 2Completed
- Sponsor
- Octapharma
- Start
- Jun 2018
- Modality
- Tissue Cells → Other Cell Types → Cell Therapies, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in Acquired fibrinogenopenia comparing Octafibrin arm with Cryoprecipitate arm (2 arms). Primary endpoint: Overall haemostatic efficacy. Started Jun 2018; status: completed.
02
Drugs
Fibrinogen humancryoprecipitate
03
Conditions
Acquired fibrinogenopenia
Beyond the preview
Go deeper on 2016-003749-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003749-27.